Ifm Investors Pty Ltd’s Eli Lilly & Co Position
Does Ifm Investors Pty Ltd own Eli Lilly & Co (LLY)? Yes — 164.7K shares worth $151M (+1.26% of its 13F portfolio) as of Q1 2026, up from 159.2K shares the prior filed quarter.
Position Value
$151M
Q1 2026
Shares
164.7K
% of Portfolio
+1.26%
Quarters Held
29
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 164.7K | $151M | +1.26% |
| Q4 2025 | 159.2K | $171,131 | +1.43% |
| Q3 2025 | 157.6K | $114M | +1.00% |
| Q2 2025 | 158.3K | $123M | +1.17% |
| Q1 2025 | 152.3K | $126M | +1.36% |
| Q3 2024 | 167.3K | $148M | +1.42% |
| Q2 2024 | 166.0K | $150M | +1.52% |
| Q1 2024 | 163.8K | $127M | +1.39% |
| Q4 2023 | 164.4K | $95,848 | +1.17% |
| Q3 2023 | 164.0K | $88M | +1.16% |
| Q2 2023 | 159.3K | $75M | +0.98% |
| Q1 2023 | 151.1K | $52M | +0.79% |
| Q4 2022 | 146.5K | $54M | +0.90% |
| Q3 2022 | 139.9K | $45M | +0.82% |
| Q2 2022 | 138.0K | $45M | +0.78% |
| Q1 2022 | 128.8K | $37M | +0.57% |
| Q4 2021 | 108.2K | $30M | +0.55% |
| Q3 2021 | 109.6K | $25M | +0.52% |
| Q2 2021 | 109.7K | $25M | +0.51% |
| Q1 2021 | 94.2K | $18M | +0.47% |
| Q4 2020 | 83.1K | $14M | +0.45% |
| Q3 2020 | 71.4K | $11M | +0.44% |
| Q2 2020 | 63.6K | $10M | +0.54% |
| Q1 2020 | 86.9K | $12M | +0.54% |
| Q4 2019 | 90.2K | $12M | +0.42% |
| Q3 2019 | 95.1K | $11M | +0.39% |
| Q2 2019 | 63.8K | $7M | +0.40% |
| Q1 2019 | 63.2K | $8M | +0.53% |
| Q4 2018 | 56.2K | $7M | +0.53% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ifm Investors Pty Ltd’s full portfolio or all institutional holders of LLY.